FDA

Monday’s Top Biopharma Movers

A few biopharma stocks made massive runs on Monday morning. The broad markets are holding near their all-time highs, and part of the run up to this level is attributed ...
Read Full Story »
Female patient on gurney

4 Biopharma Stocks Moving the Market on Wednesday

Markets have hit new intraday highs on Wednesday, continuing to climb in the wake of the White House announcements. Although the health care sector has been attacked by the U.S. ...
Read Full Story »
100 dollar bills

Why Evoke Pharma Shares Are Exploding

Evoke Pharma Inc. (NASDAQ: EVOK) saw its shares make a huge gain on Wednesday after the company issued an update that it received from the U.S. Food and Drug Administration ...
Read Full Story »
Female patient on gurney

Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results

AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) saw its shares take a sharp turn down after the company reported top-line results from its most recent pharmacokinetic (PK) study. The results were ultimately ...
Read Full Story »
Jon's friends

Wednesday’s Top Biopharma Winners

The third week of the New Year is halfway over, and a few biopharma companies made massive runs on the day. The health care sector was in trouble over the ...
Read Full Story »
Medicine pills

Why 3 Analysts Upgraded Merck Simultaneously

It may seem hard to believe that a Big Pharma drug stock might be a favorite for the year ahead when the attacks against drug pricing and competition do not ...
Read Full Story »
Doctor, Health (pulse) copy

Monday’s 4 Biggest Biopharma Movers

The second week of the New Year is now underway, and a few biotech companies made sizable runs to kick off the week. The health care sector was in trouble ...
Read Full Story »
Good heart health

Friday’s 6 Biopharma Movers That Can’t Be Ignored

There is a very positive sentiment in the health care sector considering the new Trump administration that will be taking over in just two weeks. The health care sector was ...
Read Full Story »
FDA_logo

6 Major FDA Decisions and Biopharma Catalysts Coming in January and February

Companies that reside within the biotech and pharmaceutical industries are subject to a sizable amount of risk in regards to their drug candidates passing clinical trials and gaining regulatory approval. ...
Read Full Story »
biotech word cloud

Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday

As the markets are continuing to heat up a few biotech and pharma companies made massive gains on Thursday. There is a very positive sentiment in the health care sector ...
Read Full Story »
Prescription drugs

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year. One of these stocks was ...
Read Full Story »
Jon's friends

Wednesday’s Top 5 Biopharma Movers

Biotech and pharma companies were on the move Wednesday. A few made absolutely massive gains on the day, giving more credence to the Trump rally and positive sentiment for the health care ...
Read Full Story »
Female patient on gurney

Will 2017 Be a Make or Break Year for FibroGen?

FibroGen Inc. (NASDAQ: FGEN) could be a very important stock in the biotech and pharma industries within health care in 2017. While the 35% post-election rally in FibroGen shares is ...
Read Full Story »
FDA_logo

7 Key FDA Decisions and Catalysts Expected in January and February

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »
tired frustrated unhappy business person

Cempra Shares Get Halved After Receipt of CRL From the FDA

Shares of Cempra Inc. (NASDAQ: CEMP) were halved on Thursday after the company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA). The CRL was relating ...
Read Full Story »